Arkolith/Insider Trading/HRMY/Form 4

Dierks Jeffrey

CHIEF COMMERCIAL OFFICERHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Mar 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$159K
Net Open-Market Flow
-$159K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Option exercise(M)5K$8.22$40K5K
Mar 3, 2025Sell(S)500$33.23$17K0
Mar 3, 2025Sell(S)4K$32.61$142K500

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2025Option exercise(M)5K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-006919) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML